Tariq Warsi
Senior Director at Neogene Therapeutics
Los Angeles Metropolitan Area
Overview
Work Experience
Senior Director
2023 - Current
• Overseeing process development activities for cell therapy modalities including autologous CAR-T, allogeneic, and TCR-T platforms and delivering a high-quality manufacturing process for multiple clinical stage programs • Managing a team of scientists, associates, contractors, and consultants across multiple sites • Authoring IND sections, responding to regulatory requests, and implementing a phase-appropriate approach to CMC life-cycle management • Successfully delivering milestones needed to satisfy an acquisition by a major pharmaceutical company
Entrepreneur in Residence
2023
Venture Partner
2023
Awaken Capital invests in tech-enabled platforms and the visionary entrepreneurs behind them at the early stages of their development.
Independent Consultant
2023 - 2023
• Technical operations, process development, GMP, and CMC expert in multiple modalities including cell and gene therapies, live biotherapeutic products, biologics, DNA/RNA, etc. • Expertly trained in synthetic biology, cell and molecular biology, gene editing, genomics, and bioengineering • GMP, quality, and regulatory support of novel modalities for global regulatory agencies • Scientific advisor and board member offering support on research and development, technical strategy, business development, and financing • Venture partner providing due diligence on technical aspects in various biotech sectors • Entrepreneur in residence supporting technology transfer, part-time C-suite, academic/industry relationships, and early-stage company guidance
Vice President Technical Operations
2022 - 2023
• Leading multiple high-performance teams across Process Development, Manufacturing, Quality, CMC, and Clinical Supply for genetically modified cell therapies, and successfully delivering cGMP clinical drug product to Phase 1/2 subjects • Successfully overseeing the technology transfer and manufacturing of drug substance and drug products at CDMOs, with release of multiple batches of study product for clinical trials • Drafting and submission of IND modules, regulatory feedback, and technical documents; leading to an approved IND in a novel modality • Managing a budget to ensure company operations, delivery of high-quality drug product, and CDMO contract execution • Building teams and hiring core staff across functional areas and operations verticals
Head Of Technical Operations
2020 - 2022
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Raised $83,060,623.00 from 5AM Ventures, Alexandria Venture Investments, Alta Partners, Tencent, DCVC Bio, Touchdown Ventures, University of Minnesota and Navian Capital.
Vice President of Research and Development
2020 - 2020
• Leading programs in research and development, process development, quality control, and manufacturing to create a cell therapy and exosome platform for therapeutic indications in infectious disease, oncology, and inflammation
Capricor Therapeutics is a biotechnology company focusing on cell and exosome-based therapeutics.
Raised $179,500,504.00 from Nippon Shinyaku, Cedars Sinai, CureDuchenne Ventures, Broadview Ventures, Calmedica and Beechwood Ventures.
CEO and Co-founder
2018 - 2020
• Leading scientific efforts, fundraising, growth, budgets, and the overall strategy of the company • Developing a platform to enable the discovery of novel microbes associated with marine hosts • Development of bioactive compounds, protein, and specialty chemicals in novel marine microbes
Operations Lead, Cell and Gene Therapy
2018 - 2020
• Process Development and CMC lead for live cell modalities including CAR T-cell therapies, neoantigen immunotherapy, and gene editing • Project Team Lead (PTL) for TCR-T cell therapy programs, Attribute Sciences Team Lead (ASTL) for CAR-T cell therapy program, Early Operations Lead (EOL) for neoantigen immunotherapy program
Senior Scientist
2015 - 2018
• Managing a team composed of PhD scientists, associate scientists, and senior associates to develop and execute bioassay, immunoassay, and molecular assays for release of large molecule therapeutics
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Raised $28,500,000,000.00 from Citibank and Bank of America.
Venture Partner
2015 - 2019
• Serving as an investment consultant to provide assessments and scientific due diligence for funding of biotechnology companies
Investing in entrepreneurs, inventors and scientists who aim to benefit humanity by rewriting the operating systems of life.
Staff Scientist
2014 - 2015
• Combining CRISPR genome editing tools and next-generation sequencing to address the regulation and evolution of gene expression and human disease
Education
Postdoctoral Fellow
2009 - 2011
PhD
2002 - 2009
BS
1998 - 2002